Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. The company is headquartered in New York, New York.
Click "Analyze" to generate stock analysis
DNTH Price Trend and Signals
DNTH Option Volumes & Open Interests (aggregated)
DNTH Put Call Ratios and IV (aggregated)
2025-08-28Somewhat Bullishprice_signal
Half-yearly high detected.
2025-08-26Somewhat Bullishprice_signal
Quarterly high detected.
2025-08-22Somewhat Bullishprice_signal
Quarterly high detected.
2025-08-21Somewhat Bullishprice_signal
Quarterly high detected.
2025-08-20Somewhat Bullishprice_signal
Quarterly high detected.
2025-08-19Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-08-19Somewhat Bullishprice_signal
Quarterly high detected.
2025-08-18Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.
2025-08-18Neutraloption_volume_signal
Abnormal option volume detected compared to 10-day moving average.
2025-08-18Neutraloption_volume_signal
Abnormal option volume detected compared to 20-day moving average.
2025-08-18Neutraloption_volume_signal
Abnormal option volume detected compared to 3 mon moving average.